Strategies to overcome challenges in viral-vector production

Viral vectors are ideal vehicles for gene transfer, and as the demand for them increases, many gene therapy manufacturers are struggling to scale up. But the field is evolving quickly, and new advances in cell culture can benefit several stages throughout the manufacturing pipeline. 
In this article, we discuss how these developments can help you overcome challenges and optimize HEK cell line performance. 

Key Learning Objectives:

• Understand the unique characteristics of HEK cells and how to support them
• Learn the top priorities to consider when choosing a media provider
• Discover the barriers that remain on the way to adoption